2-Chloro-4-bromobenzaldehyde

Catalog No.: 
ACJBXV973
CAS No.: 
158435-41-7
Molecular Formula: 
C7H4BrClO
Molecular Weight: 
219.46
2-Chloro-4-bromobenzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$51.00In stockInquiry
500g98%$255.00In stockInquiry
1000g98%$430.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-4-bromobenzaldehyde
IUPAC Name4-bromo-2-chlorobenzaldehyde
MDL No.MFCD08741413
Molecular FormulaC7H4BrClO
Molecular Weight219.46
SMILESClC1=C(C=O)C=CC(=C1)Br
InChI KeyDHGPLNJITGVCSG-UHFFFAOYSA-N
SynonymPS-7883 | SCHEMBL141039 | 4-bromo-2-chlorobenzaldehyde, AldrichCPR | FT-0649371 | DTXSID00555969 | A3491 | 2-Chloro-4-bromobenzaldehyde | 4-bromo-2-chloroebenzaldehyde | MFCD08741413 | BP-11514 | DHGPLNJITGVCSG-UHFFFAOYSA-N | A809930 | AM20060028 | Z10794
CAS No.158435-41-7
PubChem CID14109109

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACJBXV973 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPENX480 route compound structure diagram
    ACPENX480185315-48-4In Stock
  2. Then
  3. ACJBXV973 route product structure diagram
    ACJBXV973158435-41-7In Stock
Inquiry

2. ACJBXV973 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHWFR812 route compound structure diagram
    ACHWFR812108-37-2In Stock
  4. Then
  5. ACJBXV973 route product structure diagram
    ACJBXV973158435-41-7In Stock
Inquiry

3. ACJBXV973 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJBXV973 route product structure diagram
    ACJBXV973158435-41-7In Stock
Inquiry

Comments (0)